Thomas Scheper

773 total citations
34 papers, 568 citations indexed

About

Thomas Scheper is a scholar working on Rheumatology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Thomas Scheper has authored 34 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Rheumatology, 12 papers in Pathology and Forensic Medicine and 10 papers in Epidemiology. Recurrent topics in Thomas Scheper's work include Systemic Lupus Erythematosus Research (11 papers), Systemic Sclerosis and Related Diseases (11 papers) and Cytomegalovirus and herpesvirus research (5 papers). Thomas Scheper is often cited by papers focused on Systemic Lupus Erythematosus Research (11 papers), Systemic Sclerosis and Related Diseases (11 papers) and Cytomegalovirus and herpesvirus research (5 papers). Thomas Scheper collaborates with scholars based in Germany, Greece and United States. Thomas Scheper's co-authors include Wolfgang Meyer, Jagat J. Mukherjee, Dimitrios P. Bogdanos, Christos Liaskos, Lazaros I. Sakkas, Theodora Simopoulou, Sandra Saschenbrecker, Andreas Sauerbrei, Efthimios Dardiotis and Georgios M. Hadjigeorgiou and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Scientific Reports.

In The Last Decade

Thomas Scheper

34 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Scheper Germany 14 224 152 131 95 92 34 568
Alessio Buonavoglia Italy 14 81 0.4× 103 0.7× 57 0.4× 85 0.9× 183 2.0× 52 766
Manuela Papini Italy 20 603 2.7× 150 1.0× 233 1.8× 92 1.0× 47 0.5× 61 994
Dayna G. Diven United States 16 205 0.9× 91 0.6× 125 1.0× 47 0.5× 100 1.1× 44 730
Tomáš Slavík South Africa 16 152 0.7× 74 0.5× 48 0.4× 68 0.7× 231 2.5× 46 864
Martin P. Alphonse United States 16 105 0.5× 31 0.2× 92 0.7× 206 2.2× 260 2.8× 39 798
J. A. Grimaud France 17 204 0.9× 78 0.5× 32 0.2× 50 0.5× 151 1.6× 38 752
Sylvia L. Brice United States 16 258 1.2× 159 1.0× 171 1.3× 114 1.2× 30 0.3× 24 746
Donald Rudikoff United States 17 134 0.6× 83 0.5× 110 0.8× 104 1.1× 71 0.8× 44 758
Renu George India 11 80 0.4× 71 0.5× 40 0.3× 60 0.6× 44 0.5× 36 434
William S. Aronstein United States 15 164 0.7× 21 0.1× 186 1.4× 69 0.7× 100 1.1× 23 671

Countries citing papers authored by Thomas Scheper

Since Specialization
Citations

This map shows the geographic impact of Thomas Scheper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Scheper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Scheper more than expected).

Fields of papers citing papers by Thomas Scheper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Scheper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Scheper. The network helps show where Thomas Scheper may publish in the future.

Co-authorship network of co-authors of Thomas Scheper

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Scheper. A scholar is included among the top collaborators of Thomas Scheper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Scheper. Thomas Scheper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Warnecke, Jens M., Viola Borchardt, Andrés Moreira‐Soto, et al.. (2020). Seroprevalences of antibodies against ToRCH infectious pathogens in women of childbearing age residing in Brazil, Mexico, Germany, Poland, Turkey and China. Epidemiology and Infection. 148. e271–e271. 21 indexed citations
3.
Liaskos, Christos, Theodora Simopoulou, Christina Katsiari, et al.. (2020). A study of antigen-specific anti-cytomegalovirus antibody reactivity in patients with systemic sclerosis and concomitant anti-Ro52 antibodies. Rheumatology International. 40(10). 1689–1699. 5 indexed citations
4.
Liaskos, Christos, Theodora Simopoulou, Thomas Scheper, et al.. (2020). Antigen-specific humoral responses against Helicobacter pylori in patients with systemic sclerosis. Immunologic Research. 68(1). 39–47. 5 indexed citations
5.
Tsouris, Zisis, Christos Liaskos, Efthimios Dardiotis, et al.. (2020). A comprehensive analysis of antigen-specific autoimmune liver disease related autoantibodies in patients with multiple sclerosis. PubMed. 11(1). 7–7. 8 indexed citations
6.
Lytton, Simon D., Božena Cukrowská, Aldona Wierzbicka, et al.. (2019). Tryptophan-kynurenine profile in pediatric autoimmune hepatitis. Immunologic Research. 67(1). 39–47. 13 indexed citations
7.
Dardiotis, Efthimios, Christos Liaskos, Thomas Scheper, et al.. (2019). A comprehensive analysis of antigen-specific antibody responses against human cytomegalovirus in patients with systemic sclerosis. Clinical Immunology. 207. 87–96. 19 indexed citations
8.
Strobino, Barbara A., Katja Steinhagen, Wolfgang Meyer, et al.. (2018). A Community Study of Borrelia burgdorferi Antibodies among Individuals with Prior Lyme Disease in Endemic Areas. Healthcare. 6(2). 69–69. 5 indexed citations
9.
Liaskos, Christos, Maria Mytilinaiou, Theodora Simopoulou, et al.. (2018). Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis. Frontiers in Immunology. 9. 2835–2835. 12 indexed citations
10.
Liaskos, Christos, Theodora Simopoulou, Thomas Scheper, et al.. (2018). Multiparametric autoantibody profiling of patients with systemic sclerosis in Greece. Mediterranean Journal of Rheumatology. 29(3). 120–126. 13 indexed citations
11.
Chen, Hao, Shulin Chen, Jie Lu, et al.. (2017). Multiparametric Detection of Antibodies against Different EBV Antigens to Predict Risk for Nasopharyngeal Carcinoma in a High-Risk Population of China. Cancer Prevention Research. 10(9). 542–550. 8 indexed citations
12.
Dardiotis, Efthimios, Christos Liaskos, Vana Tsimourtou, et al.. (2017). Immune responses against Helicobacter pylori-specific antigens differentiate relapsing remitting from secondary progressive multiple sclerosis. Scientific Reports. 7(1). 7929–7929. 22 indexed citations
13.
Liaskos, Christos, Theodora Simopoulou, Thomas Scheper, et al.. (2017). Disease-related autoantibody profile in patients with systemic sclerosis. Autoimmunity. 50(7). 414–421. 74 indexed citations
14.
Liaskos, Christos, Theodora Simopoulou, Efthimios Dardiotis, et al.. (2017). Human cytomegalovirus (HCMV) UL44 and UL57 specific antibody responses in anti-HCMV-positive patients with systemic sclerosis. Clinical Rheumatology. 36(4). 863–869. 12 indexed citations
15.
Dardiotis, Efthimios, Christos Liaskos, Vana Tsimourtou, et al.. (2016). Anti-hsp60 antibody responses based on Helicobacter pylori in patients with multiple sclerosis: (ir)Relevance to disease pathogenesis. Journal of Neuroimmunology. 298. 19–23. 18 indexed citations
16.
Mytilinaiou, Maria, Wolfgang Meyer, Thomas Scheper, et al.. (2012). Diagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosis. Clinica Chimica Acta. 413(15-16). 1211–1216. 37 indexed citations
17.
Wandinger, Klaus‐Peter, Sandra Saschenbrecker, Katja Steinhagen, et al.. (2011). Diagnosis of recent primary rubella virus infections: Significance of glycoprotein-based IgM serology, IgG avidity and immunoblot analysis. Journal of Virological Methods. 174(1-2). 85–93. 19 indexed citations
18.
Probst, Christian, et al.. (2011). N-terminal disulfide-bridging of Borrelia outer surface protein C increases its diagnostic and vaccine potentials. Ticks and Tick-borne Diseases. 3(1). 1–7. 8 indexed citations
19.
Stark, Yvonne, et al.. (2006). Application of collagen matrices for cartilage tissue engineering. Experimental and Toxicologic Pathology. 57(4). 305–311. 42 indexed citations
20.
Reinecke, Martin, et al.. (1994). Automated imunoanalysis systems for monitoring mammalian cell cultivation processes. PubMed. 15(1-3). 259–269. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessio Buonavoglia Breakdown of academic impact, for papers by Manuela Papini Breakdown of academic impact, for papers by Dayna G. Diven Breakdown of academic impact, for papers by Tomáš Slavík Breakdown of academic impact, for papers by Martin P. Alphonse Breakdown of academic impact, for papers by J. A. Grimaud Breakdown of academic impact, for papers by Sylvia L. Brice Breakdown of academic impact, for papers by Donald Rudikoff Breakdown of academic impact, for papers by Renu George Breakdown of academic impact, for papers by William S. Aronstein
Rankless by CCL
2026